Impact of ovarian function on cardiovascular health in women: focus on hypertension

References

• WiinbergNHoegholmAChristensenHR24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and genderAm J Hypertens1995810 Pt 19789868845079
   PubMed Web of Science ®Google Scholar
• StamlerJStamlerRRiedlingerWFAlgeraGRobertsRHHypertension screening of 1 million Americans. Community Hypertension Evaluation Clinic (CHEC) program, 1973 through 1975JAMA19762352122992306946622
   PubMed Web of Science ®Google Scholar
• ChengSXanthakisVSullivanLMVasanRSBlood pressure tracking over the adult life course: patterns and correlates in the Framingham heart studyHypertension20126061393139923108660
   PubMed Web of Science ®Google Scholar
• RowlandMRobertsJBlood pressure levels and hypertension in persons ages 6–74 years: United States, 1976–1980Adv Data19828411110257286
   PubMedGoogle Scholar
• JacksonLVThalangeNKColeTJBlood pressure centiles for Great BritainArch Dis Child200792429830316905566
   PubMed Web of Science ®Google Scholar
• MuntnerPHeJCutlerJAWildmanRPWheltonPKTrends in blood pressure among children and adolescentsJAMA2004291172107211315126439
   PubMed Web of Science ®Google Scholar
• DubeyRKOparilSImthurnBJacksonEKSex hormones and hypertensionCardiovasc Res200253368870811861040
   PubMed Web of Science ®Google Scholar
• MeyerMRHaasEBartonMGender differences of cardiovascular disease: new perspectives for estrogen receptor signalingHypertension20064761019102616651458
   PubMed Web of Science ®Google Scholar
• BartonMMeyerMRPostmenopausal hypertension: mechanisms and therapyHypertension2009541111819470884
   PubMed Web of Science ®Google Scholar
• TaddeiSBlood pressure through aging and menopauseClimacteric200912Suppl 1364019811239
   PubMed Web of Science ®Google Scholar
• StaessenJBulpittCJFagardRLijnenPAmeryAThe influence of menopause on blood pressureJ Hum Hypertens1989364274332607517
   PubMed Web of Science ®Google Scholar
• AdamsMRRegisterTCGoldenDLWagnerJDWilliamsJKMedroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosisArterioscler Thromb Vasc Biol19971712172219012659
   PubMed Web of Science ®Google Scholar
• RosanoGMFiniMComparative cardiovascular effects of different progestins in menopauseInt J Fertil Womens Med200146524825611720197
   PubMedGoogle Scholar
• RossouwJEAndersonGLPrenticeRLRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trialJAMA2002288332133312117397
   PubMed Web of Science ®Google Scholar
• GradyDHerringtonDBittnerVCardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)JAMA20022881495712090862
   PubMed Web of Science ®Google Scholar
• YanesLLSartori-ValinottiJCIliescuRTestosterone-dependent hypertension and upregulation of intrarenal angiotensinogen in Dahl salt-sensitive ratsAm J Physiol Renal Physiol20092964F771F77919211690
   PubMed Web of Science ®Google Scholar
• ReckelhoffJFGender differences in the regulation of blood pressureHypertension20013751199120811358929
   PubMed Web of Science ®Google Scholar
• ReckelhoffJFZhangHSrivastavaKGender differences in development of hypertension in spontaneously hypertensive rats: role of the renin-angiotensin systemHypertension2000351 Pt 248048310642345
   PubMed Web of Science ®Google Scholar
• LiuPYDeathAKHandelsmanDJAndrogens and cardiovascular diseaseEndocr Rev200324331334012788802
   PubMed Web of Science ®Google Scholar
• YanesLLRomeroDGMoulanaMCardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndromeGend Med20118210311521536229
   PubMedGoogle Scholar
• CutlerJASorliePDWolzMThomTFieldsLERoccellaEJTrends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004Hypertension200852581882718852389
   PubMed Web of Science ®Google Scholar
• [No authors listed]Blood pressure studies in 14 communities. A two-stage screen for hypertensionJAMA19772372223852391576938
   PubMed Web of Science ®Google Scholar
• ZanchettiAFacchettiRCesanaGCModenaMGPirrelliASegaRMenopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological studyJ Hypertens200523122269227616269969
   PubMed Web of Science ®Google Scholar
• Pechere-BertschiABurnierMFemale sex hormones, salt, and blood pressure regulationAm J Hypertens20041710994100115485766
   PubMed Web of Science ®Google Scholar
• KharazmiEFallahMLuotoRCardiovascular diseases attributable to hysterectomy: a population-based studyActa Obstet Gynecol Scand200786121476148317917816
   PubMed Web of Science ®Google Scholar
• SchulmanIHArandaPRaijLVeronesiMArandaFJMartinRSurgical menopause increases salt sensitivity of blood pressureHypertension20064761168117416618835
   PubMed Web of Science ®Google Scholar
• SaloniaALanziRScaviniMSexual function and endocrine profile in fertile women with type 1 diabetesDiabetes Care200629231231616443879
   PubMed Web of Science ®Google Scholar
• Lamon-FavaSBarnettJBWoodsMNDifferences in serum sex hormone and plasma lipid levels in Caucasian and African-American premenopausal womenJ Clin Endocrinol Metab20059084516452015886254
   PubMed Web of Science ®Google Scholar
• StamatakiKESpinaJRangouDBChlouverakisCSPiaditisGPOvarian function in women with non-insulin dependent diabetes mellitusClin Endocrinol (Oxf)19964556156218977760
   PubMed Web of Science ®Google Scholar
• Barrett-ConnorEGiardinaEGGittAKGudatUSteinbergHOTschoepeDWomen and heart disease: the role of diabetes and hyperglycemiaArch Intern Med2004164993494215136300
   PubMedGoogle Scholar
• Snell-BergeonJKNadeauKCardiovascular disease risk in young people with type 1 diabetesJ Cardiovasc Transl Res20125444646222528676
   PubMed Web of Science ®Google Scholar
• DingELSongYMalikVSLiuSSex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysisJAMA2006295111288129916537739
   PubMed Web of Science ®Google Scholar
• StockEORedbergRCardiovascular disease in womenCurr Probl Cardiol2012371145052623047015
   PubMed Web of Science ®Google Scholar
• KannelWBBlood pressure as a cardiovascular risk factor: prevention and treatmentJAMA199627520157115768622248
   PubMed Web of Science ®Google Scholar
• HosseinpoorARHarperSLeeJHLynchJMathersCAbou-ZahrCInternational shortfall inequality in life expectancy in women and in men, 1950–2010Bull World Health Organ201290858859422893742
   PubMed Web of Science ®Google Scholar
• FordESCapewellSCoronary heart disease mortality among young adults in the US from 1980 through 2002: concealed leveling of mortality ratesJ Am Coll Cardiol200750222128213218036449
   PubMed Web of Science ®Google Scholar
• Regitz-ZagrosekVDworatzekEKintscherUDragunDSex and sex hormone-dependent cardiovascular stress responsesHypertension201361227027723184380
   PubMed Web of Science ®Google Scholar
• MelloniCBergerJSWangTYRepresentation of women in randomized clinical trials of cardiovascular disease preventionCirc Cardiovasc Qual Outcomes20103213514220160159
   PubMed Web of Science ®Google Scholar
• Worrall-CarterLSkiCScruthECampbellMPageKSystematic review of cardiovascular disease in women: assessing the riskNurs Health Sci201113452953522070582
   PubMed Web of Science ®Google Scholar
• KhotUNKhotMBBajzerCTPrevalence of conventional risk factors in patients with coronary heart diseaseJAMA2003290789890412928466
   PubMed Web of Science ®Google Scholar
• StamlerJStamlerRNeatonJDBlood pressure, systolic and diastolic, and cardiovascular risks. US population dataArch Intern Med199315355986158439223
   PubMedGoogle Scholar
• VasanRSLarsonMGLeipEPImpact of high-normal blood pressure on the risk of cardiovascular diseaseN Engl J Med2001345181291129711794147
   PubMed Web of Science ®Google Scholar
• StamlerJDyerARShekelleRBNeatonJStamlerRRelationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: findings from long-term follow-up of Chicago cohortsCardiology1993822–31912228324780
   PubMed Web of Science ®Google Scholar
• YusufSHawkenSOunpuuSEffect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyLancet2004364943893795215364185
   PubMed Web of Science ®Google Scholar
• ManziSMeilahnENRairieJEAge-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham StudyAm J Epidemiol199714554084159048514
   PubMed Web of Science ®Google Scholar
• SabioJMVargas-HitosJANavarrete-NavarreteNPrevalence of and factors associated with hypertension in young and old women with systemic lupus erythematosusJ Rheumatol20113861026103221406497
   PubMed Web of Science ®Google Scholar
• PetriMDetection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus CohortLupus20009317017510805483
   PubMed Web of Science ®Google Scholar
• NickenigGBaumerATGroheCEstrogen modulates AT1 receptor gene expression in vitro and in vivoCirculation19989722219722019631868
   PubMed Web of Science ®Google Scholar
• BrosnihanKBLiPGantenDFerrarioCMEstrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RASAm J Physiol19972736 Pt 2R1908R19159435644
   PubMedGoogle Scholar
• ErgulAShoemakerKPuettDTackettRLGender differences in the expression of endothelin receptors in human saphenous veins in vitroJ Pharmacol Exp Ther199828525115179580591
   PubMed Web of Science ®Google Scholar
• PoldermanKHStehouwerCDvan KampGJDekkerGAVerheugtFWGoorenLJInfluence of sex hormones on plasma endothelin levelsAnn Intern Med199311864294328439117
   PubMed Web of Science ®Google Scholar
• YlikorkalaOOrpanaAPuolakkaJPyoralaTViinikkaLPostmenopausal hormonal replacement decreases plasma levels of endothelin-1J Clin Endocrinol Metab19958011338433877593457
   PubMed Web of Science ®Google Scholar
• DavidFLCarvalhoMHCobraALOvarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive ratsHypertension2001383 Pt 269269611566958
   PubMed Web of Science ®Google Scholar
• InarreaPCasanovaAAlavaMAIturraldeMCadenasEMelatonin and steroid hormones activate intermembrane Cu, Zn-superoxide dismutase by means of mitochondrial cytochrome P450Free Radic Biol Med201150111575158121397009
   PubMed Web of Science ®Google Scholar
• DantasAPTostesRCFortesZBCostaSGNigroDCarvalhoMHIn vivo evidence for antioxidant potential of estrogen in microvessels of female spontaneously hypertensive ratsHypertension2002392 Pt 240541111882581
   PubMed Web of Science ®Google Scholar
• GuytonACColemanTGCowleyAVJrScheelKWManningRDJrNormanRAJrArterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertensionAm J Med19725255845944337474
   PubMed Web of Science ®Google Scholar
• NeugartenJGender and the progression of renal diseaseJ Am Soc Nephrol200213112807280912397053
   PubMed Web of Science ®Google Scholar
• SilbigerSRNeugartenJThe role of gender in the progression of renal diseaseAdv Ren Replace Ther200310131412616458
   PubMedGoogle Scholar
• MaricCSandbergKHinojosa-LabordeCGlomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17beta-estradiol in the aging Dahl salt-sensitive ratJ Am Soc Nephrol20041561546155615153565
   PubMed Web of Science ®Google Scholar
• ElliotSJKarlMBerhoMEstrogen deficiency accelerates progression of glomerulosclerosis in susceptible miceAm J Pathol200316251441144812707027
   PubMed Web of Science ®Google Scholar
• Hinojosa-LabordeCCraigTZhengWJiHHaywoodJRSandbergKOvariectomy augments hypertension in aging female Dahl salt-sensitive ratsHypertension200444440540915337736
   PubMed Web of Science ®Google Scholar
• CohenJALindseySHPirroNTBrosnihanKBGallagherPEChappellMCInfluence of estrogen depletion and salt loading on renal angiotensinogen expression in the mRen(2). Lewis strainAm J Physiol Renal Physiol20102991F35F4220462965
   PubMed Web of Science ®Google Scholar
• MankheyRWellsCCBhattiFMaricC17-beta estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidneyAm J Physiol Reg Integr Comp Physiol2006292R769R777
   Web of Science ®Google Scholar
• NegulescuOBognarILeiJDevarajanPSilbigerSNeugartenJEstradiol reverses TGF-beta1-induced mesangial cell apoptosis by a casein kinase 2-dependent mechanismKidney Int20026261989199812427123
   PubMed Web of Science ®Google Scholar
• GallagherPELiPLenhartJRChappellMCBrosnihanKBEstrogen regulation of angiotensin-converting enzyme mRNAHypertension1999331 Pt 23233289931124
   PubMed Web of Science ®Google Scholar
• MoreyAKRazandiMPedramAHuRMPrinsBALevinEROestrogen and progesterone inhibit the stimulated production of endothelin-1Biochem J1998330Pt 3109711059494073
   PubMed Web of Science ®Google Scholar
• XiaoSGillespieDGBaylisCJacksonEKDubeyRKEffects of estradiol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growthHypertension2001372 Part 264565011230350
   PubMed Web of Science ®Google Scholar
• VerthelyiDSex hormones as immunomodulators in health and diseaseInt Immunopharmacol20011698399311407317
   PubMed Web of Science ®Google Scholar
• LangTJEstrogen as an immunomodulatorClin Immunol2004113322423015507385
   PubMed Web of Science ®Google Scholar
• SalemMLEstrogen, a double-edged sword: modulation of TH1-and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine productionCurr Drug Targets Inflamm Allergy2004319710415032646
   PubMedGoogle Scholar
• VerthelyiDIAhmedSAEstrogen increases the number of plasma cells and enhances their autoantibody production in nonautoimmune C57BL/6 miceCell Immunol199818921251349790726
   PubMed Web of Science ®Google Scholar
• KandaNTamakiKEstrogen enhances immunoglobulin production by human PBMCsJ Allergy Clin Immunol19991032 Pt 12822889949320
   PubMed Web of Science ®Google Scholar
• KristensenBOAndersenPLWiikAAutoantibodies and vascular events in essential hypertension: a five-year longitudinal studyJ Hypertens19842119246530535
   PubMedGoogle Scholar
• Ofosu-AppiahWSfeirGKennellARichardTCharacterization of arterial antigens using arterial antigen-reactive T cell clones from spontaneously hypertensive ratsAm J Hypertens1997105 Pt 15355409160764
   PubMed Web of Science ®Google Scholar
• DzielakDJImmune mechanisms in experimental and essential hypertensionAm J Physiol19912603 Pt 2R459R4672000994
   PubMed Web of Science ®Google Scholar
• MansonJEHsiaJJohnsonKCEstrogen plus progestin and the risk of coronary heart diseaseN Engl J Med2003349652353412904517
   PubMed Web of Science ®Google Scholar
• HulleySGradyDBushTRandomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research GroupJAMA199828076056139718051
   PubMed Web of Science ®Google Scholar
• AndersonGLLimacherMAssafAREffects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trialJAMA2004291141701171215082697
   PubMed Web of Science ®Google Scholar
• MansonJEChlebowskiRTStefanickMLMenopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trialsJAMA2013310131353136824084921
   PubMed Web of Science ®Google Scholar
• MillerVMBlackDMBrintonEAUsing basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS)J Cardiovasc Transl Res20092322823919668346
   PubMed Web of Science ®Google Scholar
• CollinsPMoscaLGeigerMJEffects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the raloxifene use for the heart trial: results of subgroup analyses by age and other factorsCirculation2009119792293019204301
   PubMed Web of Science ®Google Scholar
• CummingsSREnsrudKDelmasPDLasofoxifene in post-menopausal women with osteoporosisN Engl J Med2010362868669620181970
   PubMed Web of Science ®Google Scholar
• KanayaAMHerringtonDVittinghoffEGlycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trialAnn Intern Med200313811912513038
   PubMed Web of Science ®Google Scholar
• FridayKEDongCFontenotRUConjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetesJ Clin Endocrinol Metab2001861485211231977
   PubMed Web of Science ®Google Scholar
• FerraraAKarterAJAckersonLMLiuJYSelbyJVHormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: the Northern California Kaiser Permanente Diabetes RegistryDiabetes Care20012471144115011423493
   PubMed Web of Science ®Google Scholar
• FernandezMCalvo-AlenJBertoliAMSystemic lupus erythematosus in a multiethnic US cohort (LUMINA L II): relationship between vascular events and the use of hormone replacement therapy in postmenopausal womenJ Clin Rheumatol200713526126517921793
   PubMed Web of Science ®Google Scholar
• HochmanJUrowitzMBIbanezDGladmanDDHormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular diseaseLupus200918431331719276299
   PubMed Web of Science ®Google Scholar
• [No authors listed]Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI TrialJAMA199527331992087807658
   PubMed Web of Science ®Google Scholar
• Wassertheil-SmollerSAndersonGPsatyBMHypertension and its treatment in postmenopausal women: baseline data from the Women’s Health InitiativeHypertension200036578078911082143
   PubMed Web of Science ®Google Scholar